BioStem Technologies, Inc. (OTCMKTS:BSEM – Get Free Report) shot up 7.1% during trading on Friday . The stock traded as high as $11.00 and last traded at $10.82. 43,477 shares changed hands during mid-day trading, a decline of 30% from the average session volume of 61,929 shares. The stock had previously closed at $10.10.
BioStem Technologies Price Performance
The firm’s 50 day moving average is $13.98 and its two-hundred day moving average is $13.83. The firm has a market capitalization of $180.38 million, a P/E ratio of 15.91 and a beta of -0.39.
BioStem Technologies Company Profile
BioStem Technologies, Inc, a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases.
Featured Stories
- Five stocks we like better than BioStem Technologies
- What is a Death Cross in Stocks?
- FedEx Delivers Another Crushing Blow to Its Stock Price
- What is a Low P/E Ratio and What Does it Tell Investors?
- Analysts Stay Bullish on Rocket Lab as Signs of a Bottom Emerge
- Best Stocks Under $10.00
- Micron Stock Will Retest All-Time Highs This Year
Receive News & Ratings for BioStem Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioStem Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
